SCHEMBL7865124

SCHEMBL7865124

O=C(CC(CCN1C(=O)c2ccccc2C1=O)C(=O)O)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.58
SMN1; SMN2 Q16637 1/20 0.50
MMP2 P08253 7/20 0.46
MMP9 P14780 7/20 0.46
MMP1 P03956 1/20 0.46
MMP3 P08254 1/20 0.46
MMP13 P45452 1/20 0.46
ALDH1A1 P00352 4/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CA12 O43570 1/20 0.45
CA9 Q16790 1/20 0.45
ALOX15 P16050 1/20 0.45
HSD17B10 Q99714 1/20 0.45
ADAM17 P78536 1/20 0.45
GSK3B P49841 1/20 0.44
KMT2A Q03164 2/20 0.44
MAPT P10636 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7861873 0.91 GSK3B (0.59) TSHRSMN1; SMN2MMP2MMP9MMP1
SCHEMBL6291932 0.89 MMP2 (0.48) TSHRMMP2MMP9MMP1MMP3
SCHEMBL6296089 0.88 GSK3B (0.55) TSHRMMP2MMP9MMP1MMP3
SCHEMBL7347186 0.88 MMP2 (0.59) TSHRMMP2MMP9MMP1MMP3
SCHEMBL4654577 0.88 MMP2 (0.59) TSHRMMP2MMP9MMP1MMP3
SCHEMBL7861661 0.88 NPC1 (0.62) MMP2MMP9MMP1MMP3MMP13
SCHEMBL7378575 0.88 MMP2 (0.59) TSHRMMP2MMP9MMP1MMP3
SCHEMBL10052675 0.85 MMP2 (0.56) TSHRMMP2MMP9
SCHEMBL7860511 0.85 MMP2 (0.47) TSHRMMP2MMP9MMP1MMP3
SCHEMBL8480599 0.84 MMP2 (0.48) MMP2MMP9MMP1MMP3MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0923529-B1 SUBSTITUTE 4-ARYLBUTYRIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITORS BAYER AG (US) 2001-09-19 EP disclosed
CN-1225620-A Substituted 4-arylbutanoic acid derivatives as matrix metalloproteinase inhibitors BAYER AG (US) 1999-08-11 CN disclosed
EP-0923529-A1 SUBSITUTE 4-ARYLBUTYRIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITORS Bayer Corporation (US) 1999-06-23 EP disclosed
US-5863915-A ENZYME INHIBITORS FOR BONES AND JOINTS BAYER CORPORATION (US) 1999-01-26 US disclosed
WO-1997043237-A1 SUBSITUTE 4-ARYLBUTYRIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITORS BAYER CORPORATION (US) 1997-11-20 WO disclosed